Diltiazem Hydrochloride

DRUG3 trials

Sponsors

University of South Florida, Radboud University Medical Center, Mayo Clinic

Conditions

Coronary VasospasmFamilial Primary Pulmonary HypertensionIdiopathic Pulmonary Arterial HypertensionMalignant Digestive System NeoplasmMicrovascular AnginaMicrovascular Ischemia of MyocardiumPrimary Pulmonary HypertensionPulmonary Arterial Hypertension

Phase 1

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Not yet recruitingNCT07456852

Mayo ClinicMalignant Digestive System Neoplasm

Start: 2026-03-31End: 2030-03-31Target: 60Updated: 2026-03-09

Phase 3

Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial

Active, not recruitingNCT04777045

Radboud University Medical CenterCoronary Vasospasm, Microvascular Angina, Microvascular Ischemia of Myocardium

Start: 2019-10-25End: 2026-12-31Target: 85Updated: 2023-03-30

Unknown Phase

Efficacy Study of Cardizem in Pulmonary Arterial Hypertension

WithdrawnNCT01645826

University of South FloridaFamilial Primary Pulmonary Hypertension, Idiopathic Pulmonary Arterial Hypertension, Primary Pulmonary Hypertension +1

Start: 2012-07-31End: 2014-09-30Updated: 2018-11-20

Related Papers

Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.

2022-04-0280 citations